NASDAQ: PLYX
Polaryx Therapeutics Inc Earnings Dates, Reports, Calls

Polaryx Therapeutics earnings were N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest PLYX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$1.4M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PLYX reported annual earnings of -$30.4M, with 703.3% growth.

PLYX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

PLYX Return on Equity

Insufficient data to display

PLYX Return on Assets

Insufficient data to display

Be the first to know when PLYX announces earnings.

PLYX Return on Capital Employed

Current Company
0%
Current Industry
-3.5%

PLYX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPGN/A-$161.45MN/A-$2.02
AARD-$48.34M-$48.77MN/A-$4.30
ACTU-$24.10M-$24.12MN/A$0.35
ABUS-$41.48M-$42.28MN/A-$0.23
ACET-$105.29M-$115.01MN/A-$20.00

Polaryx Therapeutics Earnings Reports & History FAQ

What were Polaryx Therapeutics's earnings last quarter?

Polaryx Therapeutics (NASDAQ: PLYX) reported Q3 2025 earnings per share (EPS) of -$0.03, up 50% year over year. Total PLYX earnings for the quarter were -$1.43 million. In the same quarter last year, Polaryx Therapeutics's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Polaryx Therapeutics stock.

Is Polaryx Therapeutics profitable or losing money?

As of the last Polaryx Therapeutics earnings report, Polaryx Therapeutics is currently losing money. Polaryx Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was N/A, a N/A decrease year over year.

What was PLYX's earnings growth in the past year?

As of Polaryx Therapeutics's earnings date in Q1 2026, Polaryx Therapeutics's earnings has grown year over year. PLYX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.